Journals / Erciyes Tıp Dergisi / 2008 / Cilt: 30 - Sayı: 2

Serebral tümörle karışan iki multiple skleroz olgusu

Two multiple sclerosis cases confused with cerebral tumor

Pages
111–116
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the present study, we made an effort to denote that large and multiple MS lesions should be included in the differential diagnosis of intracranial space-occupying lesions, as well.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Multiple sclerosis (MS) is an inflammatory disease of central nervous system.
📊
Key Findings & Data:The sizes of those plaques vary from milimetric values to 4-5cm.
💡
Conclusion & Impact:In the present study, we made an effort to denote that large and multiple MS lesions should be included in the differential diagnosis of intracranial space-occupying lesions, as well.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Multiple sclerosis (MS) is an inflammatory disease of central nervous system. As a result of the damage done to the myelin, lesions termed as plaques are formed in the white matter. The sizes of those plaques vary from milimetric values to 4-5cm. Large lesions of that size may behave like an abscess or tumor in the brain. Differentiating single lesions from gliomas, and distinguishing multiple lesions from tumor or abscess, are not easy processes. In the present study, we made an effort to denote that large and multiple MS lesions should be included in the differential diagnosis of intracranial space-occupying lesions, as well.

Özet

Multipl Skleroz (MS) santral sinir sisteminin otoimmün inflamatuar bir hastalığıdır. Miyelinin hasarına bağlı olarak beyaz cevherde plak adı verilen lezyonlar oluşturur. Bu plakların boyutları milimetrik birimlerden 4-5 cm'e kadar değişebilir. Bu boyuttaki büyük lezyonlar beyinde tümör veya bir apse gibi davranış sergileyebilir. Tek olan lezyonları gliomlardan ve iki veya daha çok sayıda olanları metastatik tümör veya apseden ayırmak kolay olmaz. Bu yazıda intrakraniyal yer kaplayıcı lezyonların ayırıcı tanısında, multipl karakterli ve büyük boyutlu MS lezyonlarının da hatırlanması gerekliliğini vurgulamaya çalıştık.

🔖

Cite This Article

MENKÜ, A., EKİCİ, M. A., BULUT, T., ÖKTEM, İ. S., KÖKSAL, V. (2022). Serebral tümörle karışan iki multiple skleroz olgusu. Erciyes Tıp Dergisi, Cilt: 30 - Sayı: 2, 111–116. https://ajindex.com/articles/502673

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Rolak L. Multiple Sclerosis. In: Appel SH, editor. Current Neurology. Chicago;Year Book Med.Publ. Inc: 1989. p.109-148
  2. Anderson RC, Connolly ES Jr, Komotar RJ, et al. Clinicopathological review: tumefactive demyelination in 12 year old girl. Neurosurgery 2005; 56: 1051-1057
  3. Mastrostefano R, Occhipinti E, Bigotti G, Pompili A. Multiple sclerosis plaque simulating cerebral tumor: case report and review of the literature. Neurosurgery. 1987; 21: 244-246
  4. Kirshner HS, Tsai SI, Runge VM, Price AC. Magnetic resonance imaging and other techniques in the diagnosis of multiple sclerosis. Arch Neurol 1985; 42: 859-863
  5. McDonald WI: The role of NMR imaging in the assessment of multiple sclerosis. Clin Neurol Neurosurg. 1988; 90:3-9
  6. Paty DW. Magnetic resonance in multiple sclerosis. Curr Opin Neurol Neurosurg. 1993; 6: 202-208
  7. Ormerod IE, Miller DH, McDonald WI, et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain. 1987; 110:1579-1616
  8. McDonald WI, Barnes D. Lessons from magnetic resonance imaging in multiple sclerosis. Trends Neurosci. 1989; 12: 376-379
  9. Saindane AM, Cha S, Law M, Xue X, Knopp EA, Zagzag D. Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2002; 23:1378-1386
  10. Dagher AP, Smirniotopoulos J. Tumefactive demyelinating lesions. Neuroradiology 1996; 38:560- 565
  11. Eblen F, Poremba M, Grodd W, Opitz H, Roggendorf W, Dichgans J. Myelinoclastic diffuse sclerosis (Schilder's disease): cliniconeuroradiologic correlations. Neurology 1991; 41:589- 591
  12. Ernst T, Chang L, Walot I, Huff K. Physiologic MRI of a tumefactive multiple sclerosis lesion. Neurology. 1998; 51:1486-1488
  13. Di Patre PL, Castillo V, Delavelle J, Vuillemoz S, Picard F, Landis T. “Tumor-mimicking” multiple sclerosis. Clin Neuropathol. 2003; 22:235-239
  14. Given CA 2nd, Stevens BS, Lee C. The MRI appearance of tumefactive demyelinating lesions. AJR Am J Roentgenol. 2004; 182:195-199
  15. Garell PC, Menezes AH, Baumbach G, et al. Presentation, management and follow-up of Schilder's disease. Pediatr Neurosurgery 1998; 29: 86-91.